FDA Approved: BEXAROTENE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

ANI Pharmaceuticals received FDA approval for a generic bexarotene through an Original Application (ANDA). The product is indicated for the treatment of cutaneo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

ORIG AP for BEXAROTENE (BEXAROTENE)